Flotek Raises 2026 Guidance Again on Continued Strength of International Sales

Flotek (FTK) raised its 2026 guidance again, now expecting total revenue of $360 million to $370 million and Adjusted EBITDA of $50 million to $54 million, driven by stronger international chemistry sales in the second half of 2026.

Rhea-AI Summary

Flotek (FTK) raised its 2026 guidance again, now expecting total revenue of $360 million to $370 million and Adjusted EBITDA of $50 million to $54 million, driven by stronger international chemistry sales in the second half of 2026.

The company had already increased 2026 guidance on August 4, 2026 to revenue of $340 million to $350 million and Adjusted EBITDA of $47 million to $51 million. At the midpoints of the new 2026 ranges, total revenue and Adjusted EBITDA would grow 54% and 58%, respectively, versus reported 2025 results. International chemistry revenue reached approximately $10.6 million in Q2 2026, more than a 450% sequential increase, and international chemistry sales in 2H 2026 are anticipated to potentially exceed $40 million. For 2025, Flotek reported net income of $30.5 million and Adjusted EBITDA of $32.8 million, with a reconciliation from GAAP included.

Positive

• 2026 revenue guidance raised to $360–$370 million from $340–$350 million
• 2026 Adjusted EBITDA guidance raised to $50–$54 million from $47–$51 million
• 2026 midpoint growth vs. 2025: revenue +54%, Adjusted EBITDA +58%
• Q2 2026 international chemistry revenue ~$10.6 million, >450% sequential increase
• 2H 2026 international chemistry sales anticipated to potentially exceed $40 million
• 2025 Adjusted EBITDA of $32.8 million, supporting higher 2026 profitability outlook

Negative

• Forward-looking Adjusted EBITDA guidance cannot be reconciled to GAAP net income without unreasonable efforts
• Guidance excludes non-cash contract asset amortization estimated at ~$9 million for full-year 2026

Market Context

The August 19 8-K stated PREPA termination did not affect previously issued guidance; this raise was...

Analysis

The August 19 8-K stated PREPA termination did not affect previously issued guidance; this raise was based on the international chemistry outlook, separating it from that project.

Key Figures

2026 Revenue Guidance: $360 million to $370 million 2026 Adjusted EBITDA Guidance: $50 million to $54 million Revenue Growth: 54% +5 more

2026 Revenue Guidance

$360 million to $370 million

Increased 2026 outlook

2026 Adjusted EBITDA Guidance

$50 million to $54 million

Increased 2026 outlook

Revenue Growth

54%

Midpoint of increased 2026 guidance versus reported 2025 revenue

Adjusted EBITDA Growth

58%

Midpoint of increased 2026 guidance versus reported 2025 Adjusted EBITDA

International Chemistry Revenue

$10.6 million

Second quarter of 2026

Sequential Increase

More than 450%

International chemistry revenue from first quarter to second quarter of 2026

Second-Half International Chemistry Sales

Could exceed $40 million

Expected second half of 2026

Non-Cash Contract-Asset Amortization

Approximately $9 million

Estimated full-year 2026 amount excluded from Adjusted EBITDA add-backs

Historical Context

2 past events · Latest: Aug 4

2 events

1. Aug 4

   Guidance increase

   24h Move

   +27.9%

   Raised 2026 revenue and Adjusted EBITDA guidance following strong second-quarter results

2. Aug 18

   PREPA contract update

   24h Move

   -5.8%

   PREPA ordered consortium parties to halt work while evaluating contract developments

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

adjusted ebitda, non-gaap financial measure, gaap financial measure, asset-based loan

4 terms

adjusted ebitda financial

"guidance estimates for 2026 total revenue and Adjusted EBITDA"

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

non-gaap financial measure financial

"forward-looking Adjusted EBITDA guidance, a non-GAAP financial measure"

A non-GAAP financial measure is a way companies present their financial results that excludes certain expenses or income to show how they believe their core business is performing. It matters because it can give a clearer picture of how the company is really doing, but it can also be used to make results look better than they actually are.

gaap financial measure financial

"most directly comparable GAAP financial measure, net income (loss)"

A GAAP financial measure is any number reported in a company's financial statements that is prepared according to Generally Accepted Accounting Principles (U.S. GAAP), the official set of rules and conventions for recognizing, measuring and presenting financial information. Investors care because GAAP measures—like revenue, net income, assets and liabilities—are audited and standardized across companies, so they provide a common, comparable “measuring tape” for assessing financial performance and position.

asset-based loan financial

"fluctuations in borrowings under the Company's asset-based loan"

A loan secured by a company's tangible assets—such as inventory, accounts receivable, equipment or real estate—that the lender can take or sell if the borrower can't repay. Think of it like pawning a valuable item to get cash: it gives a business faster access to funds while reducing risk for the lender, and investors watch these loans because they affect a company's liquidity, borrowing cost, and how easily creditors can recover money in trouble.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HOUSTON, Sept. 9, 2026 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced an increase to its previously disclosed guidance estimates for 2026 total revenue and Adjusted EBITDA. 

Following strong second-quarter results, on August 4, 2026, the Company raised its full-year 2026 guidance for total revenue to a range of $340 million to $350 million and for Adjusted EBITDA⁽¹⁾ to a range of $47 million to $51 million. As a result of the current outlook for international chemistry sales in the second half of 2026, the Company expects 2026 total revenue of $360 million to $370 million and Adjusted EBITDA⁽¹⁾ of $50 million to $54 million. At the midpoints of the increased 2026 guidance ranges, total revenue and Adjusted EBITDA would represent growth of 54% and 58%, respectively, compared with the reported full-year 2025 metrics⁽²⁾.

Chief Executive Officer Dr. Ryan Ezell said, "We have continued to experience growing demand, in particular in international chemistry, since increasing our 2026 guidance last month, giving us the confidence to further increase our outlook for the year.  Our momentum through 2026 reflects sustained demand for Flotek's real-time data and chemistry technologies, strong customer response to our innovative solutions, and the continued execution of our corporate strategy."

"International chemistry revenue was approximately $10.6 million in the second quarter of 2026, representing a more than 450% sequential increase from the first quarter. Supported by ongoing work in Saudi Arabia, we anticipate that international chemistry sales during the second half of 2026 could exceed $40 million. This growth, coupled with the expanding contribution from our Data Analytics segment, underscores our commitment to building a diversified and balanced platform. We believe these initiatives position Flotek for sustainable growth and continued shareholder value creation."

1. We are unable to reconcile our forward-looking Adjusted EBITDA guidance, a non-GAAP financial measure, to the most directly comparable GAAP financial measure, net income (loss), without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact of certain items that would be expected to impact the GAAP financial measure, including, among other items, certain stock-based compensation costs and interest costs related to fluctuations in borrowings under the Company's asset-based loan. These items do not impact the non-GAAP financial measure and could be material to future net income (loss). Guidance does not add back non-cash amortization of contract assets estimated to total approximately $9 million during full-year 2026. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this release for more information about these measures.
   
   
2. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this release for more information about these measures, including a reconciliation of Adjusted EBITDA, a non-GAAP measure, to the most directly comparable GAAP financial measure, net income (loss) for the year ended December 31, 2025.

Upcoming Investor Events

Flotek will participate in the Lake Street Annual Investor Conference to be held at the Metropolitan Club in New York, NY, September 10th, 2026. Flotek Chief Executive Officer Ryan Ezell will be hosting investor meetings during the event. An updated corporate presentation to be used in discussions at the conference will be posted to the Investor Relations section of Flotek's corporate website at www.flotekind.com  prior to the start of the conference.  

Some other upcoming events in which we plan to participate: 

• November 5^th, 2026: INVEST: Houston Leadership Summit (Houston, TX)
  
  
• December 3^rd, 2026: DEP Executive Series NASDAQ (New York, NY) 
  
  
• December 9^th-11^th, 2026: ROTH Deer Valley (Park City, UT)

For the latest event details visit our Investor Relations page at https://ir.flotekind.com/events 

About Flotek Industries, Inc.

Flotek Industries, Inc. is a leading chemistry and data technology company focused on servicing the Energy industry. The Company's technologies leverage near real-time data to deliver innovative solutions to maximize customer returns. Flotek has an intellectual property portfolio of over 130 patents, over 20 years of field and laboratory data, and a global presence in more than 59 countries.

Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions, aiming to reduce the environmental impact of energy on land, air, water and people.

Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit www.flotekind.com.

Forward-Looking Statements

Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934).  These statements include, without limitation, statements regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects, including the Company's financial guidance, including forecasted revenue and Adjusted EBITDA ranges and forecasted international chemistry revenues. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Risks beyond the Company's control, including ongoing and potential military conflicts in the Middle East and related logistics and supply chain disruptions, increased costs and security risks that could affect the Company's ability to deliver products to the region, may cause actual results to differ materially from anticipated results. Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.

FLOTEK INDUSTRIES, INC.
Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings
(in thousands)

	Year Ended December 31, 2025
Net income	$      30,528
Interest expense	3,937
Income tax benefit	(10,873)
Depreciation and amortization	1,836
EBITDA (Non-GAAP) (1)	$      25,428
Stock compensation expense	2,300
Severance and retirement	575
Contingent liability revaluation	(127)
Gain on disposal of asset	(7)
Non-Recurring professional fees (2)	4,621
Adjusted EBITDA (Non-GAAP) (1)	$      32,790

1. Management believes that EBITDA and Adjusted EBITDA for the year ended December 31, 2025 are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods.  Management views the adjustments made to net income for certain non-cash or non-recurring items noted above to be outside of the Company's normal operating results.  Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial, compensation and operational objectives.  Adjusted EBITDA as presented above does not add back non-cash amortization of contract assets totaling $6.3 million.

1. Includes $4.4 million of expenses related to an asset acquisition.

View original content to download multimedia:https://www.prnewswire.com/news-releases/flotek-raises-2026-guidance-again-on-continued-strength-of-international-sales-302873053.html

SOURCE Flotek Industries, Inc.

FAQ

What 2025 figures does Flotek use as the baseline for its 2026 guidance increases?

For 2025, Flotek reported net income of $30.5 million and Adjusted EBITDA of $32.8 million. Management uses these metrics as the baseline for the indicated 54% revenue and 58% Adjusted EBITDA growth at the midpoints of the 2026 guidance ranges.

Why does Flotek say it cannot fully reconcile its 2026 Adjusted EBITDA guidance to GAAP net income?

The company states it cannot predict with reasonable certainty the impact of certain items that affect GAAP net income, including stock-based compensation and interest costs related to borrowings under its asset-based loan. These items do not affect Adjusted EBITDA but could be material to future net income.

How does Flotek treat amortization of contract assets in its 2026 guidance and 2025 Adjusted EBITDA figures?

The 2026 guidance does not add back non-cash amortization of contract assets, which is estimated at approximately $9 million for full-year 2026. For 2025, Adjusted EBITDA presented in the reconciliation did not add back non-cash amortization of contract assets totaling $6.3 million.

What is included in Flotek’s 2025 Adjusted EBITDA reconciliation from net income?

For 2025, Adjusted EBITDA of $32.8 million is derived from net income of $30.5 million by adjusting for interest expense, income tax benefit, depreciation and amortization, stock compensation expense, severance and retirement costs, contingent liability revaluation, gain on disposal of an asset, and approximately $4.6 million of non-recurring professional fees, which include $4.4 million related to an asset acquisition.

Which upcoming investor events will Flotek participate in during late 2026?

Flotek plans to participate in several events, including the Lake Street Annual Investor Conference on September 10, 2026 in New York, the INVEST: Houston Leadership Summit on November 5, 2026 in Houston, the DEP Executive Series NASDAQ on December 3, 2026 in New York, and the ROTH Deer Valley event from December 9–11, 2026 in Park City, Utah.

How can investors access Flotek’s updated corporate presentation for the upcoming conference?

An updated corporate presentation that will be used for investor meetings at the Lake Street Annual Investor Conference is expected to be posted in the Investor Relations section of Flotek’s website at www.flotekind.com prior to the start of the conference. Additional event details are available at https://ir.flotekind.com/events.